Financial Statements — CTNM
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 20.16 | 42.63 | 20.78 | 22.47 | 40.89 | 77.23 | 16.26 |
| Short-term Investments | 226.17 | 139.77 | 154.70 | 168.24 | 173.02 | 141.42 | 101.64 |
| Total Current Assets | 252.96 | 184.93 | 176.84 | 192.13 | 215.14 | 220.32 | 119.71 |
| Property, Plant & Equipment | 1.06 | 0.88 | 0.86 | 0.89 | 0.89 | 0.80 | 0.76 |
| Total Non-current Assets* | 8.39 | 5.92 | 6.05 | 6.13 | 0.89 | 1.03 | 3.85 |
| Total Assets | 261.35 | 190.85 | 182.89 | 198.26 | 216.03 | 221.36 | 123.56 |
| Accounts Payable | 1.50 | 0.79 | 2.00 | 3.65 | 1.40 | 0.73 | 0.57 |
| Total Current Liabilities | 6.66 | 6.36 | 7.21 | 8.95 | 5.81 | 3.74 | 6.23 |
| Total Non-current Liabilities* | 4.65 | 4.02 | 4.28 | 4.55 | 0.00 | 0.11 | 0.34 |
| Total Liabilities | 11.31 | 10.38 | 11.50 | 13.50 | 5.81 | 3.85 | 6.57 |
| Retained Earnings | (191.84) | (162.22) | (149.43) | (133.39) | (102.84) | (92.57) | (83.56) |
| Total Stockholder Equity | 250.04 | 180.47 | 171.39 | 184.77 | 210.23 | 217.50 | (75.63) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Total Revenue | -- | -- | -- | 0.00 | -- | 0.00 | 0.00 | 0.00 | -- |
| Research & Development | 11.65 | 12.76 | 10.99 | 14.06 | 13.71 | 13.02 | 9.73 | 7.90 | 7.78 |
| Selling, General & Admin | 5.26 | 4.36 | 3.94 | 3.84 | 4.40 | 4.03 | 3.25 | 3.04 | 2.15 |
| Total Operating Expenses | 16.90 | 17.11 | 14.93 | 17.90 | 18.11 | 17.05 | 12.97 | 10.94 | 9.93 |
| Operating Income | (16.90) | (17.11) | (14.93) | (17.90) | (18.11) | (17.05) | (12.97) | (10.94) | (9.93) |
| Pretax Income | -- | -- | -- | -- | -- | (14.56) | (10.27) | (9.01) | (8.42) |
| Tax Provision | -- | -- | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (14.46) | (15.16) | (12.79) | (16.04) | (15.99) | (14.56) | (10.27) | (9.01) | (8.42) |
| Basic EPS | (0.39) | (0.48) | (0.45) | (0.62) | (0.62) | 2.16 | (0.40) | (0.39) | (3.55) |
| Diluted EPS | (0.39) | -- | -- | -- | -- | (0.57) | (0.40) | (0.39) | -- |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | (16.27) | (13.04) | (12.20) | (15.66) | (14.41) | (10.20) | (6.17) | (8.50) | (7.97) |
| Capital Expenditures | 0.31 | 0.04 | 0.10 | 0.04 | 0.05 | 0.17 | 0.08 | 0.12 | 0.15 |
| Free Cash Flow* | (16.58) | (13.08) | (12.29) | (15.70) | (14.46) | (10.37) | (6.25) | (8.62) | (8.12) |
| Investing Cash Flow | (39.31) | (47.45) | 14.94 | 13.88 | 14.92 | (9.39) | (30.18) | (38.90) | 8.73 |
| Financing Cash Flow | 0.13 | 93.47 | 19.11 | 0.09 | 0.02 | 0.64 | 0.01 | 108.36 | (0.02) |
* Derived from reported values
